HN1998000073A - DERIVATIVES OF 9 - OXIMA ERYTHROMYCIN - Google Patents

DERIVATIVES OF 9 - OXIMA ERYTHROMYCIN

Info

Publication number
HN1998000073A
HN1998000073A HN1998000073A HN1998000073A HN1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A
Authority
HN
Honduras
Prior art keywords
compounds
derivatives
oxima
erythromycin
well
Prior art date
Application number
HN1998000073A
Other languages
Spanish (es)
Inventor
Yong Jin Wu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1998000073A publication Critical patent/HN1998000073A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A LOS NUEVOS DERIVADOS 3 CETO 9 OXIMA 11,12 CARBAZATO O CARBAMATO DE LA 6 0METILERITROMICINA A. LOS COMPUESTOS DE ESTA INVENCION SON UTILES COMO ANTIBIOTICOS EN MAMIFEROS, INCLUIDO EL HOMBRE, ASI COMO EN PECES Y AVES. LOS COMPUESTOS DE LA PRESENTE INVENCION CON ANTIBIOTICOS MACROLIDOS DE AMPLIO ESPECTRO QUE SON EFICACES CONTRA LAS INFECCIONES PROVOCADAS POR DETERMINADAS BACTERIAS GRAM POSITIVAS Y GRAM NEGATIVAS, ASI COMO POR PROTOZOOS. ESTOS COMPUESTOS TIENEN LA ESTRUCTURA QUIMICA (I), EN LA QUE R1, R2, R6 Y X SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTETHIS INVENTION IS REFERRED TO THE NEW DERIVATIVES 3 CETO 9 OXIME 11.12 CARBAZATE OR CARBAMATE OF 6 METHYLERITHROMYCIN A. THE COMPOUNDS OF THIS INVENTION ARE USEFUL AS ANTIBIOTICS IN MAMMALS, INCLUDING MAN, AS WELL AS IN FISH AND BIRDS. THE COMPOUNDS OF THE PRESENT INVENTION WITH BROAD SPECTRUM MACROLID ANTIBIOTICS THAT ARE EFFECTIVE AGAINST INFECTIONS CAUSED BY CERTAIN NEGATIVE GRAM BACTERIA, AS WELL AS PROTOZOA. THESE COMPOUNDS HAVE THE CHEMICAL STRUCTURE (I), IN WHICH R1, R2, R6 AND X ARE FUNCTIONAL GROUPS DESCRIBED IN THE FILE

HN1998000073A 1997-06-11 1998-05-19 DERIVATIVES OF 9 - OXIMA ERYTHROMYCIN HN1998000073A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
HN1998000073A true HN1998000073A (en) 1999-01-08

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1998000073A HN1998000073A (en) 1997-06-11 1998-05-19 DERIVATIVES OF 9 - OXIMA ERYTHROMYCIN

Country Status (31)

Country Link
EP (1) EP0988308A1 (en)
JP (1) JP2000513026A (en)
KR (1) KR20010013660A (en)
CN (1) CN1259135A (en)
AP (1) AP9801253A0 (en)
AR (1) AR012244A1 (en)
AU (1) AU7226798A (en)
BG (1) BG103947A (en)
BR (1) BR9810021A (en)
CA (1) CA2293335A1 (en)
CO (1) CO4940506A1 (en)
CZ (1) CZ9904388A3 (en)
EA (1) EA199901016A1 (en)
GT (1) GT199800074A (en)
HN (1) HN1998000073A (en)
HR (1) HRP980316A2 (en)
HU (1) HUP0002252A3 (en)
ID (1) ID24529A (en)
IL (1) IL132767A0 (en)
IS (1) IS5251A (en)
MA (1) MA26505A1 (en)
NO (1) NO996108L (en)
OA (1) OA11225A (en)
PA (1) PA8451801A1 (en)
PE (1) PE79899A1 (en)
PL (1) PL337606A1 (en)
TN (1) TNSN98083A1 (en)
TR (1) TR199902995T2 (en)
TW (1) TW448174B (en)
WO (1) WO1998056800A1 (en)
ZA (1) ZA985018B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (en) * 1997-10-29 1999-02-09 Monsanto Co DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
WO2000017218A1 (en) 1998-09-22 2000-03-30 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (en) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
WO2000063224A2 (en) * 1999-04-16 2000-10-26 Kosan Biosciences, Inc. Macrolide antiinfective agents
IL145739A0 (en) 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
ES2208334T3 (en) * 1999-06-07 2004-06-16 Abbott Laboratories CETOLIDE DERIVATIVES OF 6-0 CARBAMATE.
ID27331A (en) * 1999-09-29 2001-03-29 Pfizer Prod Inc MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
AR043050A1 (en) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
CN102816194A (en) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 Macrocyclic compounds and methods of making and using the same
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
CN102245195B (en) 2008-10-24 2016-01-13 森普拉制药公司 Use the biophylaxis of the macrolide containing triazole
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
CN102146085B (en) * 2010-02-09 2014-03-26 北京理工大学 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof
WO2011119604A1 (en) 2010-03-22 2011-09-29 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
AU2011255464C1 (en) 2010-05-20 2017-02-23 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc Hydrogen bond forming fluoro ketolides for treating diseases
EP2830632A4 (en) 2012-03-27 2015-10-21 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (en) * 1994-04-08 1997-01-10 Roussel Uclaf New erythromycin derivatives, their preparation process and their use as drugs.

Also Published As

Publication number Publication date
CN1259135A (en) 2000-07-05
IL132767A0 (en) 2001-03-19
HUP0002252A3 (en) 2002-01-28
AU7226798A (en) 1998-12-30
GT199800074A (en) 1999-11-27
CO4940506A1 (en) 2000-07-24
HRP980316A2 (en) 1999-04-30
CA2293335A1 (en) 1998-12-17
BR9810021A (en) 2000-09-19
CZ9904388A3 (en) 2002-10-16
AP9801253A0 (en) 1999-12-04
TW448174B (en) 2001-08-01
MA26505A1 (en) 2004-12-20
WO1998056800A1 (en) 1998-12-17
EA199901016A1 (en) 2000-06-26
NO996108D0 (en) 1999-12-10
AR012244A1 (en) 2000-09-27
KR20010013660A (en) 2001-02-26
TR199902995T2 (en) 2000-02-21
NO996108L (en) 2000-02-10
ID24529A (en) 2000-07-20
TNSN98083A1 (en) 2005-03-15
PL337606A1 (en) 2000-08-28
ZA985018B (en) 1999-12-10
BG103947A (en) 2000-07-31
IS5251A (en) 1999-11-16
PA8451801A1 (en) 2000-05-24
OA11225A (en) 2003-07-17
JP2000513026A (en) 2000-10-03
HUP0002252A2 (en) 2000-12-28
EP0988308A1 (en) 2000-03-29
PE79899A1 (en) 1999-08-25

Similar Documents

Publication Publication Date Title
HN1998000073A (en) DERIVATIVES OF 9 - OXIMA ERYTHROMYCIN
GT199800075A (en) DERIVATIVES OF MACROLIDES C-4 "SUBSTITUTED.
KR960704868A (en) Cyclodepsipeptide Compound
PA8461701A1 (en) DERIVATIVES OF 9-AMINO-3-KETO Erythromycin
ATE311209T1 (en) MEDICAL DEVICES CONTAINING COMBINATIONS OF ANTISEPTIC AND ANTIBIOTIC AGENTS
GT199900093A (en) TRIFLUOROMETILPIRROLCARBOXAMIDAS.
GT199700124A (en) BICYCLE AMINE DERIVATIVES
PA8462201A1 (en) SUBSTITUTE BENZENE COMPOUNDS, PROCEDURES FOR THEIR PREPARATION, AND HERBICIDE AND DEFOLIANT COMPOSITIONS CONTAINING THEM
GT199900192A (en) NEW MACROLID ANTIBIOTICS.
DK41791D0 (en) ANTIBIOTIC CC 1065 ANALOGUE
GT199900198A (en) AZALIDAS OF 13 MEMBERS AND ITS USE AS ANTIBIOTIC AGENTS.
GT199800162A (en) TRICYCLIC ERYTHROMYCINE DERIVATIVES.
AR027688A1 (en) HETEROCICLIC ACILSULFIMIDS, PROCEDURE FOR THEIR PREPARATION, AGENTS THAT CONTAIN THEM AND THEIR EMPLOYMENT AS AGENTS TO COMBAT HARMFUL ANIMALS
ES2055808T3 (en) AGENT FOR THE PROTECTION OF PLANTS AGAINST DISEASES.
GT200000049A (en) CHEMICAL COMPOUNDS.
GT199700104A (en) PROCEDURES AND INTERMEDIATES TO PREPARE SUBSTITUTED CHROMANOL DERIVATIVES.
ATE242970T1 (en) PHOTOSENSITIVE COMPOSITION
DK0410615T3 (en) Antiparasitic agent
ES2061811T3 (en) USE OF CONJUGATED GAMMA-OXYBUTENOLIDE COMPOUNDS TO TREAT ULCERA.
BR8504387A (en) PROCESS FOR THE PREPARATION OF ACYLATED SACARINE DERIVATIVES, PESTICIDE COMPOSITES AND PROCESSES FOR COMBATING PEST AND PREPARING COMPOSITIONS
HN1999000064A (en) DERIVATIVES OF 2 "-DESOXY HYGROMYCIN"
GT200000185A (en) HYGROMYCIN DERIVATIVES
AR023273A1 (en) SYNTHESIS OF ANTIBIOTICS CARBAMATO CETOLIDOS.
GT199800065A (en) DERIVATIVES OF ERYTHROMYCIN.
BR8600203A (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED FURAZANS, PLEASANT COMPOSITES, PROCESSES FOR COMBATING PEST AND FOR THE PREPARATION OF COMPOSITIONS